BioLineRx BLRX
NASDAQ BLRX
$2.67 -0.02 (-0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

BioLineRx (BLRX) Receivables - Net (2010 - 2025)

BioLineRx (BLRX) posted quarterly Receivables - Net of $46000.0 for Q4 2025, down 98.14% year-over-year from $2.5 million in Q4 2024, and down 41.03% quarter-over-quarter from $78000.0 in Q2 2025.

Analysis

BioLineRx (BLRX) Receivables - Net (2010 - 2025) Analysis & Trends

BioLineRx's Receivables - Net history runs 5 years deep, the most recent figure standing at $46000.0 for Q4 2025.

  • In Q4 2025, Receivables - Net fell 98.14% year-over-year to $46000.0; the TTM figure through Dec 2025 stood at $46000.0 (down 98.14% YoY), while the FY2025 annual figure was $46000.0, down 98.14% from the prior year.
  • Receivables - Net for Q4 2025 stood at $46000.0, down from $78000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $3.6 million in Q3 2024, with the low at $46000.0 in Q4 2025.
  • The 3-year median for Receivables - Net is $2.0 million (2024), against an average of $1.8 million.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Net jumped 591.62% in 2024, then sank 98.14% in 2025.
  • BioLineRx's Receivables - Net stood at $358000.0 in 2023, then surged by 591.62% to $2.5 million in 2024, then tumbled by 98.14% to $46000.0 in 2025.
  • Business Quant data shows BLRX's Receivables - Net at $46000.0 in Q4 2025, $78000.0 in Q2 2025, and $1.5 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 BioLineRx 6.64 Bn 6.64 Bn 235,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 46,000.00
Jun 30, 2025 78,000.00
Mar 31, 2025 1.47 Mn
Dec 31, 2024 2.48 Mn
Sep 30, 2024 3.61 Mn
Jun 30, 2024 3.18 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 358,000.00
Dec 31, 2020 613,000.00
Dec 31, 2019 848,000.00
Dec 31, 2018 491,000.00
Dec 31, 2010 5.29 Mn